Naringenin inhibits migration of lung cancer cells via the inhibition of matrix metalloproteinases-2 and -9

Chang,Huai‑Lu; Chang,Yuh‑Ming; Lai,Shih‑Chan; Chen,Ke‑Min; Wang,Kuan‑Chu; Chiu,Tsu‑Ting; Chang,Fu‑Hsin; Hsu,Li‑Sung

doi:10.3892/etm.2016.3994

February-2017 Volume 13 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

February-2017 Volume 13 Issue 2

Full Size Image

Article

Naringenin inhibits migration of lung cancer cells via the inhibition of matrix metalloproteinases-2 and -9

Authors:
- Huai‑Lu Chang
- Yuh‑Ming Chang
- Shih‑Chan Lai
- Ke‑Min Chen
- Kuan‑Chu Wang
- Tsu‑Ting Chiu
- Fu‑Hsin Chang
- Li‑Sung Hsu
View Affiliations / Copyright

Affiliations: Department of Thoracic Surgery of Zouying Branch, Kaohsiung Armed Force General Hospital, Kaohsiung 81342, Taiwan, R.O.C., Department of Neurology, Division of Internal Medicine, Hsinchu Mackay Memorial Hospital, Hsinchu 30071, Taiwan, R.O.C., Department of Parasitology, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C., School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C., Department of Biomedical Research, Asia‑Pacific Biotech Developing, Kaohsiung 80681, Taiwan, R.O.C., Institutes of Biochemistry, Microbiology and Immunology, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C.
Pages: 739-744
|
Published online on: December 22, 2016

https://doi.org/10.3892/etm.2016.3994
Expand metrics +

Abstract

Lung cancer is among the most common causes of cancer‑related mortality. It has a high mortality rate and resistance to chemotherapy due to its high metastatic potential. Naringenin, a bioactive compound identified in several fruits, displays anti‑inflammatory and antitumor effects. Furthermore, naringenin mitigates the migration of several human cancer cell types. However, the effects of naringenin on lung cancer remain unclear. The current study investigated the mechanisms of naringenin on the migration of lung cancer A549 cells. The results indicate that significant alteration in A549 cell proliferation was observed in response to naringenin (0‑300 µM) treatment for 24 and 48 h. Furthermore, a dose‑dependent migration inhibition of A549 in the presence of naringenin was observed by healing and transwell migration assays. In addition, a zymography assay revealed that naringenin exhibited a concentration‑dependent inhibition of matrix metalloproteinase (MMP)‑2 and ‑9 activities. Furthermore, naringenin also inhibited the activities of AKT in a dose‑dependent manner. These observations indicated that naringenin inhibited the migration of lung cancer A549 cells through several mechanisms, including the inhibition of AKT activities and reduction of MMP-2 and -9 activities.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Naringenin inhibits migration of lung cancer cells via the inhibition of matrix metalloproteinases-2 and -9

This article is mentioned in:

Abstract

Related Articles